Marcos V. Santana

De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning

Marcos V. Santana, Floriano Paes Silva · BMC Chemistry · 2021 · 74 citations · Full text

COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

Mário Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas et al. · Memórias do Instituto Oswaldo Cruz · 2020 · 46 citations · Full text

Pharmaceutical Innovation, Molecular Biology, Molecular Targets +17

Synthesis and antimicrobial evaluation of promising 7-arylamino-5,8-dioxo-5,8-dihydroisoquinoline-4-carboxylates and their halogenated amino compounds for treating Gram-negative bacterial infections

Juliana S. Novais, Vinícius R. Campos, Ana Carolina J. A. Silva et al. · RSC Advances · 2017 · 30 citations · Full text

Gram-negative Bacterial Infections, Bioorganic Chemistry, Antimicrobial Evaluation +18

Antileishmanial Thioureas: Synthesis, Biological Activity and <i>in Silico</i> Evaluations of New Promising Derivatives

Gil Mendes Viana, Deivid Costa Soares, Marcos V. Santana et al. · Chemical and Pharmaceutical Bulletin · 2017 · 26 citations · Full text

Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors Dazoxiben and Ozagrel

P.C Sathler, Marcos V. Santana, André Luiz Lourenço et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2013 · 18 citations · Full text